Hiroshi Sakuma (Department of Brain and Neural Science, Tokyo Metropolitan Institute of Medi cal Science)
Session information
International Symposium
[IS1] International Symposium 1:Cutting Edge ―Treatment of Autoimmune Encephalitis―
Fri. Jun 3, 2022 3:20 PM - 5:20 PM Room 3 (Conference Hall A)
Chair: Kazuhiro Muramatsu(Department of Pediatrics, Jichi Medical University),Hiroshi Sakuma(Department of Brain & Neural Science, Tokyo Metropolitan Institute of Medical Science)
【企画・趣旨のねらい】
Anti—NMDA receptor encephalitis(NMDARE)and myelin oligodendrocyte glycoprotein antibody—associated disease(MOGAD)are two major central nervous system(CNS)syndromes caused by autoantibodies against neuronal or glial antigens. Although observational studies have suggested the beneficial roles of high—dose corticosteroids and plasma exchange for the treatment of attacks, problems remain unsolved in the treatment strategy for refractory or frequently relapsing cases. In this symposium, we invite experts in both NMDARE and MOGAD to share their perspectives on the current trends in the treatment of autoantibody—mediated CNS diseases.
Yoshitaka Mizobe,Kazuhiro Muramatsu,Takahiro Ikeda,Hitoshi Osaka,Takanori Yamagata (The Department of Pediatrics, Jichi Medical University, Tochigi, Japan)
[IS1-3] The clinical courses of three cases of MOG antibody—associated demyelinating diseases(MOGAD)
Naomi Hino—Fukuyo (Tohoku Medical and Pharmaceutical University, Sendai, Japan)
Margherita Nosadini (Paediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.,Neuroimmunology group, Paediatric Research Institute‘Città della Speranza', Padova, Italy.)
Yael Hacohen (Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology)